Aarti Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ZOLPIDEM TARTRATE, with a corresponding US DMF Number 19440.
Remarkably, this DMF maintains an Active status since its submission on May 16, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 08, 2012, and payment made on December 14, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II